Drug diversion is more common than most organizations want to acknowledge. According to SAMHSA and the American Nurses Association, roughly 1 in 10 healthcare workers abuse drugs — and that rate is made more serious by the direct access healthcare staff have to controlled substances.
An undetected diversion event carries consequences well beyond the individual involved:
- Patient safety risks from tampered or substituted medications
- DEA fines and regulatory scrutiny following a confirmed diversion incident
- Reputational damage that can affect staff trust and public perception
- Documentation gaps that leave hospitals exposed during audits
How ControlCheck Addresses the Problem
ControlCheck is Bluesight’s drug diversion surveillance software, built for hospital pharmacy and compliance teams. Rather than relying on manual audits or reactive investigations, ControlCheck uses unsupervised machine learning to continuously analyze controlled substance data and surface anomalous patterns before they escalate.
Capabilities include:
- Controlled substance surveillance across all care areas and dispensing points
- Automated behavioral analytics that flag non-compliant documentation practices
- Full audit trail visibility into inventory, movement, and administration records
- Early identification of staff members who may need intervention and support
A complete controlled substance record means your team is not piecing together evidence after the fact.
Why Proactive Monitoring Matters
Investigating only after a complaint or incident leaves significant gaps. By the time a pattern becomes obvious, the harm has often already occurred. Proactive drug diversion monitoring software closes that gap by surfacing risk signals as part of routine operations.
For more on how hospitals are approaching diversion detection, see Bluesight’s Diversion Trends Report.